title: A phase II study for the evaluation of quinine as a modulator of multidrug resistance in non-Hodgkin's lymphoma.
authors.affiliation: Département de Médecine, Institut Bergonié, Bordeaux, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Soubeyran
authors.forename: Amine
authors.initials: A
authors.lastname: Masmoudi
authors.forename: Christelle
authors.initials: C
authors.lastname: Blanc-Bisson
authors.forename: Nathalie
authors.initials: N
authors.lastname: Quénel
authors.forename: Bernard
authors.initials: B
authors.lastname: Hoerni
authors.forename: Ricardo
authors.initials: R
authors.lastname: Bellott
authors.forename: Jacques
authors.initials: J
authors.lastname: Robert
authors.forename: Isabelle
authors.initials: I
authors.lastname: Soubeyran
authors.forename: Catherine
authors.initials: C
authors.lastname: Donamaria
authors.forename: Matthieu
authors.initials: M
authors.lastname: Molimard
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple / Q000187:drug effects*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008875:Middle Aged; D011803:Quinine / Q000627:therapeutic use*
chemical_list: D011803:Quinine